BPC-157 ships as a lyophilized — freeze-dried — powder rather than a ready-to-use solution. That form keeps the peptide chemically stable on the shelf, but it means a lab has to reconstitute it into liquid form before it can be pipetted into any assay.
What reconstitution requires
- The lyophilized vial itself, kept sealed until the point of use.
- A diluent — most commonly bacteriostatic water, chosen because its trace benzyl alcohol content limits microbial growth in a solution that may be drawn from more than once.
- A syringe sized to the target volume, along with standard sterile technique.
Reconstitution sequence
Standard practice is to let the sealed vial come up to room temperature before opening, since condensation forming on cold lyophilized powder can interfere with how cleanly it goes into solution. The diluent is then added slowly, directed down the inside wall of the vial rather than straight onto the powder, and the vial is swirled gently rather than shaken; vigorous agitation can disrupt peptide bonds at the air-liquid interface and introduce unwanted foaming. This sequence is broadly the same one used across most lyophilized research peptides.
Calculating working concentrations
Because a vial's labeled peptide content is a mass, not a ready-to-use concentration, a lab still has to work out how much diluent to add to reach whatever concentration a given protocol calls for. That calculation is straightforward arithmetic — total peptide mass divided by final volume — but it's worth double-checking against the specific vial on hand, since BPC-157 is commonly supplied in more than one mass per vial, and assuming the wrong starting mass is one of the more avoidable sources of error in an otherwise simple reconstitution step.
Storage before reconstitution
In its lyophilized state, BPC-157 is comparatively forgiving to handle. Its short chain length and the absence of a disulfide bond — the structural feature that makes many other peptides fragile — mean it tolerates brief exposure to room temperature better than most. Even so, long-term storage calls for keeping vials cold, dry, and shielded from light, the same baseline principles that apply across the broader research-peptide category, covered in storing research peptides.
Storage after reconstitution
Once dissolved, the solution behaves differently: it should be kept refrigerated and used within whatever window the lab's own protocol establishes, since a peptide in solution is more exposed to hydrolysis and microbial contamination than its freeze-dried counterpart. Repeated freeze-thaw cycling is one of the more common ways a working solution loses potency across a multi-week project, which is why some labs aliquot a freshly reconstituted batch into single-use portions rather than refreezing and rethawing the same vial repeatedly. Reconstitution materials and the BPC-157 research vial itself are both available as standalone items.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.